Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949611 · ClinicalTrials.gov registry record · NA
Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT00949611: Completed NA study, sponsored by Mayo Clinic.
NCT00949611 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 79 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00949611, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
Emphasis in treating osteoporosis has been on T-scores rather than overall fracture risk. Fracture Risk Assessment Tool (FRAX) supports a risk sensitive approach to osteoporosis treatment by providing an absolute fracture risk. FRAX combined with a decision aid may promote a shared decision making approach with patients, allowing the clinician and patient to weigh potential fracture risk (without treatment), versus risk reduction with medication (including side effects and costs). OSTEOPOROSIS CHOICE II will test the effectiveness of: * FRAX * FRAX + decision aid * Usual care (no decision aid and no FRAX given to clinician)
Interventions
- BEHAVIORAL FRAX + Decision Aid
- BEHAVIORAL FRAX estimated fracture risk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-02 |
| Phase | NA |
What the finished NCT00949611 record still lists
NCT00949611 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which FRAX + Decision Aid is the first listed.
NCT00949611 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00949611 about?
NCT00949611 is a clinical study titled "Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians". Emphasis in treating osteoporosis has been on T-scores rather than overall fracture risk. Fracture Risk Assessment Tool (FRAX) supports a risk sensitive approach to osteoporosis treatment by providing an absolute fracture risk. FRAX combined with a decision aid may promote a shared decision making a...
What is the current status of trial NCT00949611?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2009-05. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00949611?
The interventions under investigation include: FRAX + Decision Aid (BEHAVIORAL), FRAX estimated fracture risk (BEHAVIORAL).
Who is sponsoring clinical trial NCT00949611?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00949611's enrollment target sits among peer trials
79 1060th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia